Global capabilities
Delivering value beyond the test result
At Mayo Clinic Laboratories, laboratory medicine is about more than a test result — it’s about everything that contributes to providing answers for your patients. We develop individualized support solutions for each client that extend through all aspects of the relationship to ensure the delivery of answers, not just results.
Specialized testing areas include:
Global logistics and shipping
We develop unique relationships with each client to individualize logistics support, which is coordinated by a local team who ensures a seamless process before the first patient specimen is sent. Our specialists collaborate with packaging suppliers to create unique solutions that extend the stability of specimens traveling around the world.
These experts ensure specimens are handled carefully and efficiently through close connections to shipping carriers. The air carriers we work with are experienced with processing clinical specimens.
Optimized, expeditious processing
We recognize many medical conditions have a window of opportunity for the best possible outcomes. Our tests and processes are optimized to better serve patients and deliver results with outcomes in mind. We do not triage specimens across a network of labs or use a batch-testing business model. Result turnaround times are expedited by:
- Running tests continuously – your samples are processed alongside those from Mayo Clinic.
- A testing approach that incorporates comprehensive panels and algorithms when appropriate.
- Utilization of Lean and Six Sigma processes.
Reliable connectivity
We offer technology solutions to help our clients connect to us, including a secure online portal with interfacing capabilities that allows you to easily order tests and receive results. Our solutions include:
- Client-friendly test ordering through MayoLINK, which is available in eight languages.
- Expansive website with links to our open- access test catalog, which is updated daily and features comprehensive clinical information, including specimen requirements; clinical and interpretative information; performance; sample test reports; setup files; and pricing.
- 30 country-specific toll-free numbers.
News and updates
The latest
Dr. Bill Morice shares how clinical diagnostics are expanding to guide treatment and enable clinicians to target therapies more precisely.
December 10, 2021 The laboratory industry is breathing a sigh of relief with the passage of S. 610, the Protecting Medicare and American Farmers from Sequester[...]
Today's Highlights Include: Mayo Clinic research on oral pill vaccines, Omicron vs. delta-What we know so far, and how a COVID home test works and when to use one.
This week on "Answers From the Lab," William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update with Bobbi Pritt, M.D. This week, Dr. Morice and Dr. Pritt step back and look at where the COVID-19 pandemic stands now, and they consider the potential effects that the omicron variant, expanded testing availability, and the upcoming holidays all could have.
This week’s research roundup features: The management of cancer symptoms and treatment-induced side effects with cannabis or cannabinoids.
The quest to create a test pinpointing the source of the rare, testicular cancer-associated illness successfully concluded in the summer of 2021.
In a recent Wall Street Journal article, the director of Mayo Clinic’s Infectious Diseases Serology Laboratory, Elitza Theel, Ph.D., was among a group of experts discussing the value of COVID-19 antibody testing.
Starting December 7, you will notice enhancements to MayoClinicLabs.com. We are building a better website for you, our clients, to ensure the best experience possible. We’re moving toward a simpler, more intuitive and customized experience, making it easier to do business with us.
Topic's Include: Mayo Clinic Q&A podcast: Boosters reduce vulnerability to COVID-19 variants, what Mayo experts know about the omicron variant, and mental health and the holidays: Resilience.
While Gregor Heinrich never could have imagined that testicular cancer was related to his problems with his vision and gait, learning he was positive for KLHL11 protein biomarkers meant he could receive treatment for both the cancer and the illness behind it.
Today's Highlights Include: What are omicron variant symptoms? Everything to know about the latest COVID-19 strain, it’s flu season, and here’s why you should get your flu shot this winter, and will the vaccines stop Omicron? Scientists are racing to find out.
In this episode of Lab Medicine Rounds, Justin Kreuter, M.D., and Thomas Grys, Ph.D., Associate Professor of Laboratory Medicine and Pathology in the Mayo Clinic College of Medicine and Science and co-director of Microbiology at Mayo Clinic’s Arizona campus, discuss valley fever testing and the importance of clinical context.
This week on "Answers From the Lab," William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update with Bobbi Pritt, M.D. As the omicron variant of SARS-CoV-2 gains attention and generates concern, Dr. Morice and Dr. Pritt discuss what’s being done to learn more about this new variant and the effects it could have on the fight against COVID-19.